Center for Scientific Review; Notice of Closed Meetings, 24222-24223 [2013-09579]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
24222
Federal Register / Vol. 78, No. 79 / Wednesday, April 24, 2013 / Notices
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Conference Call: Dial: 888–324–9651,
Participant Passcode: 5124072.
Cost: The meeting is free and open to the
public.
Webcast Live: https://videocast.nih.gov/.
Registration: https://iprcc.nih.gov/.
Deadlines: Notification of intent to present
oral comments: Thursday, May 23, 2013, by
5:00 p.m. ET.
Submission of written/electronic statement
for oral comments: Monday, May 27, 2013,
by 5:00 p.m. ET.
Submission of written comments:
Wednesday, May 29, 2013, by 5:00 p.m. ET.
Access: Medical Center Metro (Red Line)
Visitor Information: https://www.nih.gov/
about/visitor/index.htm.
Contact Person: Linda L. Porter, Ph.D.,
Health Science Policy Advisor, Officer of the
Director, National Institute of Neurological
Disorders and Stroke, NIH, 31 Center Drive,
Room 8A03, Bethesda, MD 20892, Phone:
(301) 496–9271, Email: IPRCC
PublicInquiries@mail.nih.gov.
Please Note:
Any member of the public interested in
presenting oral comments to the Committee
must notify the Contact Person listed on this
notice by 5:00 p.m. ET on Thursday, May 23,
2013, with their request to present oral
comments at the meeting. Interested
individuals and representatives of
organizations must submit a written/
electronic copy of the oral statement/
comments including a brief description of the
organization represented by 5:00 p.m. ET on
Monday, May 27, 2013.
Statements submitted will become a part of
the public record. Only one representative of
an organization will be allowed to present
oral comments on behalf of that organization,
and presentations will be limited to three to
five minutes per speaker, depending on
number of speakers to be accommodated
within the allotted time. Speakers will be
assigned a time to speak in the order of the
date and time when their request to speak is
received, along with the required submission
of the written/electronic statement by the
specified deadline. If special
accommodations are needed, please email
the Contact Person listed above.
In addition, any interested person may
submit written comments to the IPRCC prior
to the meeting by sending the comments to
the Contact Person listed on this notice by
5:00 p.m. ET, Wednesday, May 29, 2013. The
comments should include the name and,
when applicable, the business or professional
affiliation of the interested person. All
written comments received by the deadlines
for both oral and written public comments
will be provided to the IPRCC for their
consideration and will become part of the
public record.
The meeting will be open to the public
through a conference call phone number and
webcast live on the Internet. Members of the
public who participate using the conference
call phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with the
conference call or webcast, please call
VerDate Mar<15>2010
18:05 Apr 23, 2013
Jkt 229001
Operator Service on (301) 496–4517 for
conference call issues and the NIH IT Service
Desk at (301) 496–4357, toll free (866) 319–
4357, for webcast issues.
Individuals who participate in person or by
using these electronic services and who need
special assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a request to
the Contact Person listed on this notice at
least seven days prior to the meeting.
As a part of security procedures, attendees
should be prepared to present a photo ID
during the security process to get on the NIH
campus. For a full description, please see:
https://www.nih.gov/about/
visitorsecurity.htm.
Information about the IPRCC is available
on the Web site: https://iprcc.nih.gov/
Dated: April 18, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–09589 Filed 4–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Cancer
Diagnostics and Treatments.
Date: May 3, 2013.
Time: 1:00 p.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Zhang-Zhi Hu, MD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6186,
MSC 7804, Bethesda, MD 20892, (301) 594–
2414, huzhuang@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: April 17, 2013
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–09580 Filed 4–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; R15:
Rheumatology, Skeletal Biology, Dental,
Muscle, Biomaterial and Tissue Engineering.
Date: May 21–22, 2013
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Aruna K Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, beheraak@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA Panel:
Investigations on Primary Immunodeficiency
Diseases.
Date: May 21, 2013.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Scott Jakes, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4198,
MSC 7812, Bethesda, MD 20892, 301–495–
1506, jakesse@mail.nih.gov.
E:\FR\FM\24APN1.SGM
24APN1
Federal Register / Vol. 78, No. 79 / Wednesday, April 24, 2013 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA RM–
11016: Regional Comprehensive
Metabolomics Resource Cores.
Date: May 22–23, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Ping Fan, MD, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5154,
MSC 7840, Bethesda, MD 20892, 301–408–
9971, fanp@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mentored
Research Scientist Development Award in
Metabolomics.
Date: May 22, 2013.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting)
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–435–
1024, allen.richon@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Name of Committee: National Human
Genome Research Institute Initial Review
Group; Genome Research Review Committee.
Date: June 6, 2013.
Time: 11:30 a.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 3rd floor Conf. Room 3146, 5635
Fishers Lane, Rockville, MD 20892,
(Telephone Conference Call).
Contact Person: Ken D. Nakamura, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Human Genome Research
Institute, National Institutes of Health,
Bethesda, MD 20892, 301 402–0838.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: April 18, 2013
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Dated: April 18, 2013
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2013–09584 Filed 4–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; NIH Support for
Conferences and Scientific Meetings.
Date: May 13, 2013.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892.
Contact Person: Barbara J. Nelson, Ph.D.,
Scientific Review Officer, Office of Grants
Management & Scientific Review, National
Center for Advancing Translational Sciences
(NCATS), National Institutes of Health, 6701
Democracy Blvd., Room 1080, 1 Dem. Plaza,
Bethesda, MD 20892–4874, 301–435–0806,
nelsonbj@mail.nih.gov.
Dated: April 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–09579 Filed 4–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
tkelley on DSK3SPTVN1PROD with NOTICES
National Institutes of Health
VerDate Mar<15>2010
18:05 Apr 23, 2013
Jkt 229001
24223
PO 00000
Frm 00074
Fmt 4703
Sfmt 9990
[FR Doc. 2013–09582 Filed 4–23–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel; Center for
Multiscale Simulations in the Human
Circulation.
Date: June 25, 2013.
Time: 10:00 a.m. to 9:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: John K. Hayes, Ph.D.,
Scientific Review Officer, National Institute
of Biomedical Imaging and Bioengineering,
National Institutes of Health, 6707
Democracy Boulevard, Room 959, Bethesda,
MD 20892, 301–451–3398,
hayesj@mail.nih.gov.
Dated: April 18, 2013.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–09588 Filed 4–23–13; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\24APN1.SGM
24APN1
]]>Agencies
[Federal Register Volume 78, Number 79 (Wednesday, April 24, 2013)]
[Notices]
[Pages 24222-24223]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-09579]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; R15: Rheumatology, Skeletal Biology, Dental, Muscle,
Biomaterial and Tissue Engineering.
Date: May 21-22, 2013
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Aruna K Behera, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD
20892, 301-435-6809, beheraak@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA Panel: Investigations on Primary Immunodeficiency
Diseases.
Date: May 21, 2013.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Scott Jakes, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4198, MSC 7812, Bethesda, MD 20892, 301-495-
1506, jakesse@mail.nih.gov.
[[Page 24223]]
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA RM-11016: Regional Comprehensive Metabolomics Resource
Cores.
Date: May 22-23, 2013.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Ping Fan, MD, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5154, MSC 7840, Bethesda, MD 20892, 301-408-
9971, fanp@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Mentored Research Scientist Development Award in
Metabolomics.
Date: May 22, 2013.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting)
Contact Person: Allen Richon, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6184, MSC 7892, Bethesda, MD 20892, 301-435-
1024, allen.richon@nih.hhs.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: April 17, 2013.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-09579 Filed 4-23-13; 8:45 am]
BILLING CODE 4140-01-P
